Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126152784 | 12615278 | 4 | F | 20160626 | 20160913 | 20160802 | 20160919 | EXP | FR-PFIZER INC-2016363811 | PFIZER | 10.00 | YR | M | Y | 32.00000 | KG | 20160919 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126152784 | 12615278 | 1 | PS | Tazocilline | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous drip | UNK | Y | 50750 | INJECTION | ||||||||
| 126152784 | 12615278 | 2 | SS | Vancomycine | VANCOMYCIN | 1 | UNK | U | 62911 | INJECTION | |||||||||
| 126152784 | 12615278 | 3 | SS | DOLIPRANE | ACETAMINOPHEN | 1 | Oral | UNK | D | 0 | |||||||||
| 126152784 | 12615278 | 4 | SS | PERFALGAN | ACETAMINOPHEN | 1 | Intravenous drip | UNK | Y | 0 | |||||||||
| 126152784 | 12615278 | 5 | SS | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Intravenous drip | UNK | Y | 0 | |||||||||
| 126152784 | 12615278 | 6 | SS | CIFLOX /00697202/ | CIPROFLOXACIN HYDROCHLORIDE | 1 | Intravenous drip | UNK | Y | 0 | |||||||||
| 126152784 | 12615278 | 7 | SS | FORTUM /00559701/ | CEFTAZIDIME | 1 | Intravenous drip | UNK | Y | 0 | |||||||||
| 126152784 | 12615278 | 8 | SS | FORTUM /00559701/ | CEFTAZIDIME | 1 | UNK | Y | Y | 0 | |||||||||
| 126152784 | 12615278 | 9 | SS | FORTUM /00559701/ | CEFTAZIDIME | 1 | UNK | Y | Y | 0 | |||||||||
| 126152784 | 12615278 | 10 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous drip | UNK | U | 0 | |||||||||
| 126152784 | 12615278 | 11 | SS | ZECLAR | CLARITHROMYCIN | 1 | UNK | Y | 0 | ||||||||||
| 126152784 | 12615278 | 12 | C | ADVIL | IBUPROFEN | 1 | UNK | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126152784 | 12615278 | LT |
| 126152784 | 12615278 | DS |
| 126152784 | 12615278 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126152784 | 12615278 | Cholestasis | Cholestasis |
| 126152784 | 12615278 | Eosinophilia | |
| 126152784 | 12615278 | Hepatitis | |
| 126152784 | 12615278 | Hepatocellular injury | Hepatocellular injury |
| 126152784 | 12615278 | Hyperbilirubinaemia | Hyperbilirubinaemia |
| 126152784 | 12615278 | Prothrombin time shortened |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126152784 | 12615278 | 1 | 20160629 | 20160703 | 0 | |
| 126152784 | 12615278 | 2 | 20160707 | 20160725 | 0 | |
| 126152784 | 12615278 | 3 | 20160624 | 20160625 | 0 | |
| 126152784 | 12615278 | 4 | 20160626 | 20160630 | 0 | |
| 126152784 | 12615278 | 5 | 20160626 | 20160628 | 0 | |
| 126152784 | 12615278 | 6 | 20160627 | 20160703 | 0 | |
| 126152784 | 12615278 | 7 | 20160710 | 20160715 | 0 | |
| 126152784 | 12615278 | 8 | 20160717 | 20160718 | 0 | |
| 126152784 | 12615278 | 10 | 20160627 | 0 | ||
| 126152784 | 12615278 | 11 | 20160701 | 20160711 | 0 |